Article type
Year
Abstract
Introduction: Early diagnosis and treatment, by conventional methods, of patients with systemic lupus (SLE), systemic sclerosis (pss) and poly/dermato myositis (PDM) remarkably improve prognosis resulting in an increase in number of chronic patients in whom underlying abnormalities persist. Development of internal organ associations leading to life-threatening conditions such as lung disease has become increasingly common.